Your browser doesn't support javascript.
loading
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
Caruso, Simona; De Angelis, Biagio; Del Bufalo, Francesca; Ciccone, Roselia; Donsante, Samantha; Volpe, Gabriele; Manni, Simona; Guercio, Marika; Pezzella, Michele; Iaffaldano, Laura; Silvestris, Domenico Alessandro; Sinibaldi, Matilde; Di Cecca, Stefano; Pitisci, Angela; Velardi, Enrico; Merli, Pietro; Algeri, Mattia; Lodi, Mariachiara; Paganelli, Valeria; Serafini, Marta; Riminucci, Mara; Locatelli, Franco; Quintarelli, Concetta.
Afiliación
  • Caruso S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • De Angelis B; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy. biagio.deangelis@opbg.net.
  • Del Bufalo F; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Ciccone R; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Donsante S; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Volpe G; Research Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00146, Rome, Italy.
  • Manni S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Guercio M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Pezzella M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Iaffaldano L; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Silvestris DA; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Sinibaldi M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Di Cecca S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Pitisci A; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Velardi E; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Merli P; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Algeri M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Lodi M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Paganelli V; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Serafini M; Department of Pediatrics, Tettamanti Research Center, Fondazione MBBM/San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
  • Riminucci M; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Locatelli F; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy. franco.locatelli@opbg.net.
  • Quintarelli C; Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy. franco.locatelli@opbg.net.
J Hematol Oncol ; 15(1): 163, 2022 11 05.
Article en En | MEDLINE | ID: mdl-36335396

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Child / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Child / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia